Fox Business interviewed Pfizer CEO Albert Bourla Wednesday during a report on the recent bounce-back of their stock price. Bourla discussed reasons why Pfizer is once again profitable, including the pharmaceutical company’s expectation to reap massive profits via the sale of cancer drugs in the near future.

“Oncology, it is our new Covid,” Bourla said. “We did what we did with Covid. We are very proud to have saved the world but it is behind us now, we want to do once more and I think oncology is our best chance to do it.”

The Fox Business host asked how Pfizer will win big within oncology, to which Bourla said his company’s drugs will significantly increase the survival rate of cancer patients.

The irony is not lost on the informed viewer, as it has been reported that the Covid vaccination, which Pfizer is chief among it’s manufacturers, causes cancer.

While the Covid vaccine is indicated to cause cancer, the recent push to chemically transgender more children is another possible source of new customers, as it has been documented that transgender drugs cause cancer as well.

The statements from the CEO only serve to confirm the company’s problem, reaction, solution business tactic, as it was reported months back that the firm had invested big into cancer drugs.

BREAKING: The Civil War Has Begun— Discover The Globalist Kill List